Esperion Therapeutics (ESPR) Total Debt (QoQ) (2014 - 2026)
Esperion Therapeutics (ESPR) Total Debt (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Esperion Therapeutics | 799.30 Mn | 643.14 Mn | 45.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.30% |
| Dec 31, 2025 | 0.37% |
| Sep 30, 2025 | 3.55% |
| Jun 30, 2025 | 3.54% |
| Mar 31, 2025 | 0.34% |
| Jun 30, 2018 | -74.79% |
| Mar 31, 2018 | -42.30% |
| Dec 31, 2017 | -29.34% |
| Sep 30, 2017 | -22.32% |
| Jun 30, 2017 | -18.00% |
| Mar 31, 2017 | -14.98% |
| Dec 31, 2016 | -12.83% |
| Sep 30, 2016 | -11.17% |
| Jun 30, 2016 | -9.84% |
| Mar 31, 2016 | -8.85% |
| Dec 31, 2015 | -7.94% |
| Sep 30, 2015 | -4.86% |
| Jun 30, 2015 | 0.31% |
| Mar 31, 2015 | 0.33% |
| Dec 31, 2014 | -1.22% |